1. Home
  2. CERS vs DRDB Comparison

CERS vs DRDB Comparison

Compare CERS & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • DRDB
  • Stock Information
  • Founded
  • CERS 1991
  • DRDB 2024
  • Country
  • CERS United States
  • DRDB United States
  • Employees
  • CERS N/A
  • DRDB N/A
  • Industry
  • CERS EDP Services
  • DRDB
  • Sector
  • CERS Technology
  • DRDB
  • Exchange
  • CERS Nasdaq
  • DRDB Nasdaq
  • Market Cap
  • CERS 347.3M
  • DRDB 307.3M
  • IPO Year
  • CERS 1997
  • DRDB 2024
  • Fundamental
  • Price
  • CERS $1.29
  • DRDB $10.18
  • Analyst Decision
  • CERS Strong Buy
  • DRDB
  • Analyst Count
  • CERS 2
  • DRDB 0
  • Target Price
  • CERS $3.50
  • DRDB N/A
  • AVG Volume (30 Days)
  • CERS 1.0M
  • DRDB 186.0K
  • Earning Date
  • CERS 05-01-2025
  • DRDB 01-01-0001
  • Dividend Yield
  • CERS N/A
  • DRDB N/A
  • EPS Growth
  • CERS N/A
  • DRDB N/A
  • EPS
  • CERS N/A
  • DRDB N/A
  • Revenue
  • CERS $185,144,000.00
  • DRDB N/A
  • Revenue This Year
  • CERS $25.57
  • DRDB N/A
  • Revenue Next Year
  • CERS $10.54
  • DRDB N/A
  • P/E Ratio
  • CERS N/A
  • DRDB $581.82
  • Revenue Growth
  • CERS 13.06
  • DRDB N/A
  • 52 Week Low
  • CERS $1.12
  • DRDB $9.87
  • 52 Week High
  • CERS $2.54
  • DRDB $10.19
  • Technical
  • Relative Strength Index (RSI)
  • CERS 45.00
  • DRDB N/A
  • Support Level
  • CERS $1.22
  • DRDB N/A
  • Resistance Level
  • CERS $1.38
  • DRDB N/A
  • Average True Range (ATR)
  • CERS 0.07
  • DRDB 0.00
  • MACD
  • CERS 0.00
  • DRDB 0.00
  • Stochastic Oscillator
  • CERS 26.92
  • DRDB 0.00

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About DRDB Roman DBDR Acquisition Corp. II Ordinary shares

Roman DBDR Acquisition Corp II is a blank check company.

Share on Social Networks: